Neurocrine Biosciences Inc
NBIX
|
|
| |
|
| Trading Volume | 20,765 |
|
|
153.02 - 106.07 |
| Market Cap Full | $ 12.6B |
Quarterly +
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Q1 | - | 1.1% | 4.6% | -15.3% |
| Q2 | - | - | -4.7% | -6.8% |
| Q3 | - | - | -9.2% | 19.3% |
| Q4 | - | - | 5.7% | 17.9% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2026 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2025 | |||||||||||
| 1.1 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 6.1 | -6.7 | 5.7 | -4.2 | 2.6 | -0.9 | 5.2 | -9.2 | - | - | - | - |
| 2023 | |||||||||||
| -7.1 | -7.1 | -1.8 | -0.2 | -11.4 | 5.3 | 8.1 | 6.9 | 3.3 | -1.4 | 5.1 | 13 |
| 2022 | |||||||||||
| -7.2 | 13.7 | 4.3 | -4 | 3.2 | 4.9 | -3.9 | 12 | 1.2 | 8.4 | 10.4 | -6 |
| 2021 | |||||||||||
| 17.9 | -3.2 | -11.1 | -2.8 | 1.8 | 1.1 | -4.5 | 2.4 | 0.8 | 9.9 | -21 | 2.3 |
EPS
| 2023 | 2022 | 2021 | |
|---|---|---|---|
| Q1 | -0.8 | 0.1 | 0.3 |
| Q2 | 1 | -0.2 | 0.4 |
| Q3 | 0.8 | 0.7 | 0.2 |
| Q4 | 0 | 0.9 | -0.1 |
| A | 0.98 | 1.6 | 0.9 |